About Us
ADR-AC GmbH is a Swiss research and service company founded in 2006 as a spin-off company of the University of Bern. It offers drug allergy diagnosis throughout Switzerland and neighbouring countries, as well as consultation and in vitro testing for potential allergic reactions to new drugs in phase 1-3 trials.
ADR-AC has a unique blend of clinical and laboratory expertise and is committed to serving healthcare professionals and their patients by the dedicated development and application of in vitro tests.
Press releases
ADR-AC to launch a laboratory analysis service for memory T-cell...
ADR-AC to launch a laboratory analysis service for memory T-cell response against the 2019 novel Coronavirus The new “SARS-CoV-2... read more
22.12.2020 • By ADR-AC GmbH